Your provider will review potential risks, benefits, contraindications, and possible side effects before treatment begins
The present study (Nicholls et al, 2025) SURPASS-CVOT (Study of Tirzepatide Compared with Dulaglutide on Major Cardiovascular Events in Participants with Type 2 Diabetes) was a double-blind, randomised, active-comparator study to determine non-inferiority of tirzepatide 15 mg (or highest tolerated dose) versus dulaglutide 1.5 mg in terms of 3-point MACE, in people aged 50 years with type 2 diabetes and established CVD
How It Works (Step-by-Step) Quick questionnaire Provide personal info Set up Shed account Choose NAD+ injections or nasal spray Make payment Medical consultation Payment processed if prescription issued Prescription shipped to your home Geographic Availability All states except AK, AR, CA, IN, MI, MN, SC Clinical Oversight and Safety Board-certified healthcare providers Unlimited texting to health coach included in monthly prescription fee Easy scheduling of follow-up appointments through Shed portal Reputable, accredited 503A and 503B pharmacies for compounded meds Licensed and follows all compounding standards set by the US Pharmacopeia (USP) Treatments Offered NAD+ injections and nasal spray GLP-1 and other weight-loss medication
These effects are compounded by reduced physical activity and anabolic resistance, which together drive a cycle of progressive muscle loss and fat accumulation
We use this method because it bypasses the digestive hurdles that make standard supplements less effective
1.1.3 Keeps abreast of changes in practice and in the practice environment that affect individual competence and legislative scope of practice
